Page 107 - GPD-1-2
P. 107

Gene & Protein in Disease                                                  Structure and function of USP7



               95(9): 1978–1988.                                  https://doi.org/10.1158/1535-7163.MCT-09-0097
               https://doi.org/10.1016/j.mayocp.2020.04.039    163. Nicholson B, Suresh Kumar KG,  2011, The multifaceted
                                                                  roles of USP7: New therapeutic opportunities. Cell Biochem
            153. Poch D, Mandel J, 2021, Pulmonary hypertension.  Ann
               Intern Med, 174(4): ITC49–ITC64.                   Biophys, 60(1–2): 61–68.
               https://doi.org/10.7326/AITC202104200           164. Reverdy C, Conrath S, Lopez R, et al., 2012, Discovery of
                                                                  specific inhibitors of human USP7/HAUSP deubiquitinating
            154. Zhu Y, Zhang Q, Yan  X,  et al., 2021,  Ubiquitin-specific   enzyme. Chem Biol, 19(4): 467–477.
               protease 7 mediates platelet-derived growth factor-induced
               pulmonary arterial smooth muscle cells proliferation. Pulm      https://doi.org/10.1016/j.chembiol.2012.02.007
               Circ, 11(4): 20458940211046131.                 165. Altun M, Kramer HB, Willems LI, et al., 2011, Activity-based
               https://doi.org/10.1177/20458940211046131          chemical proteomics accelerates inhibitor development for
                                                                  deubiquitylating enzymes. Chem Biol, 18(11): 1401–1412.
            155. Uhlen M, Zhang C, Lee S, et al., 2017, A pathology atlas
               of the human cancer transcriptome.  Science, 357(6352):      https://doi.org/10.1016/j.chembiol.2011.08.018
               eaan2507.                                       166. Fan YH, Cheng J, Vasudevan SA, et al., 2013, USP7 inhibitor
               https://doi.org/10.1126/science.aan2507            P22077 inhibits neuroblastoma growth via inducing p53-
                                                                  mediated apoptosis. Cell Death Dis, 4(10): e867.
            156. Davoodpour  P,  Landström  M,  Welsh  M,  2007,  Reduced
               tumor growth in vivo and increased c-Abl activity in PC3      https://doi.org/10.1038/cddis.2013.400
               prostate cancer cells overexpressing the Shb adapter protein.   167. Shin SB, Kim CH, Jang HR, 2020, Combination of inhibitors
               BMC Cancer, 7: 161.                                of USP7 and PLK1 has a strong synergism against paclitaxel
            157. Qu CF, Chen TY, Wang YT, et al., 2018, Primary prevention   resistance. Int J Mol Sci, 21(22): 8629.
               model of liver cancer in rural China. Zhonghua Zhong Liu      https://doi.org/10.3390/ijms21228629
               Za Zhi, 40(7): 481–489.
                                                               168. Fu C, Zhu X, Xu P, et al., 2019, Pharmacological inhibition
               https://doi.org/10.3760/cma.j.issn.0253-3766.2018.07.001  of USP7 promotes antitumor immunity and contributes to
            158. Dong L, Yu L, Bai C, et al., 2018, USP27-mediated cyclin E   colon cancer therapy. Oncol Targets Ther, 12: 609–617.
               stabilization drives cell cycle progression and hepatocellular      https://doi.org/10.2147/OTT.S182806
               tumorigenesis. Oncogene, 37(20): 2702–2713.
                                                               169. Yang L, Cao N, Miao Y, et al., 2021, Morin acts as a USP7
               https://doi.org/10.1038/s41388-018-0137-z          inhibitor to hold back the migration of rheumatoid arthritis
            159. Zhang W, Zhang J, Xu C,  et al., 2020, Ubiquitin-specific   fibroblast-like synoviocytes in a “Prickle1-mTORC2”
               protease 7 is a drug-able target that promotes hepatocellular   dependent manner. Mol Nutr Food Res, 65(19): e2100367.
               carcinoma and chemoresistance. Cancer Cell Int, 20: 28.      https://doi.org/10.1002/mnfr.202100367
               https://doi.org/10.1186/s12935-020-1109-2       170. Yu Z, Wei X, Liu L, et al., 2022, Indirubin-3’-monoxime acts
            160. Cai JB, Shi GM, Dong ZR,  et al., 2015, Ubiquitin-  as proteasome inhibitor: Therapeutic application in multiple
               specific  protease 7  accelerates  p14(ARF)  degradation by   myeloma. EBioMedicine, 78: 103950.
               deubiquitinating thyroid hormone receptor-interacting      https://doi.org/10.1016/j.ebiom.2022.103950
               protein 12 and promotes hepatocellular carcinoma
               progression. Hepatology, 61(5): 1603–1614.      171. Hu T, Zhang J, Sha B, et al., 2019, Targeting the overexpressed
                                                                  USP7 inhibits esophageal squamous cell carcinoma cell
               https://doi.org/10.1002/hep.27682
                                                                  growth by inducing NOXA-mediated apoptosis.  Mol
            161. Chauhan D, Tian Z, Nicholson B,  et al., 2012, A small   Carcinog, 58(1): 42–54.
               molecule inhibitor of ubiquitin-specific protease-7 induces
               apoptosis in multiple myeloma cells and overcomes      https://doi.org/10.1002/mc.22905
               bortezomib resistance. Cancer Cell, 22(3): 345–358.  172. Becker K, Marchenko ND, Palacios G, et al., 2008, A role of
                                                                  HAUSP in tumor suppression in a human colon carcinoma
            162. Colland F, Formstecher E, Jacq X, et al., 2009, Small-molecule
               inhibitor of USP7/HAUSP ubiquitin protease stabilizes and   xenograft model. Cell Cycle, 7(9): 1205–1213.
               activates p53 in cells. Mol Cancer Ther, 8(8): 2286–2295.      https://doi.org/10.4161/cc.7.9.5756











            Volume 1 Issue 2 (2022)                         17                     https://doi.org/10.36922/gpd.v1i2.118
   102   103   104   105   106   107   108   109   110   111   112